NEW YORK, March 2 - Former Millennium Pharmaceuticals chief technology officer Frank Lee has joined EngeneOS, a start-up biomolecular engineering company based in Cambridge, Mass.

Lee will become president and CEO of EngeneOS (pronounced ingenious), which counts Eric Lander as a member of its scientific advisory board. The company hopes to develop molecular machines using a combination of genomics, biotechnology, and the physical sciences, Lee said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.